To include your compound in the COVID-19 Resource Center, submit it here.

Navelbine vinorelbine tartrate injection: Phase II data; marketed to treat non-small cell lung cancer (NSCLC)

In a Phase II trial in 164 NSCLC patients, Navelbine plus gemcitabine was comparable

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE